Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis - ScienceDirect
Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis
Frontiers | Prognostic Factors and Effect of Adjuvant Chemoradiation Following Chemotherapy in Resected Pancreatic Cancer Patients With Lymph Node Metastasis or R1 Resection
Frontiers | Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival
A Review of Recent Real-World Evidence Data in Metastatic Pancreatic Cancer
Five-year survival rates among PDAC patients with and without DM and... | Download Scientific Diagram
Cancers | Free Full-Text | Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy
Clinical significance and prospective molecular mechanism of C‑C motif chemokine receptors in patients with early‑stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study | Scientific Reports
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients' experience within a population-based study - Tai-Jan Chiu, Yung-Yeh Su, Shih-Hung Yang, Chung-Pin Li, Li-Yuan Bai, Nai-Jung Chiang, Shih-Chang
Clinical features and prognostic impact of asymptomatic pancreatic cancer | Scientific Reports
The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data | Scientific Reports
Kaplan-Meier analysis of overall survival of patients with PDAC of the... | Download Scientific Diagram
Survival and Prognostic Factors in Pancreatic and Ampullary Cancer | Anticancer Research
Effect of Perioperative CEA and CA24-2 on Prognosis of Early Resectable Pancreatic Ductal Adenocarcinoma
![PDF] Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8faa1d8f68b65770edd2aeca36796df9f4345753/6-Figure2-1.png "PDF] Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. | Semantic Scholar")
PDF] Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. | Semantic Scholar
Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis
The impact of adjuvant therapy on outcome in UICC stage I pancreatic cancer - Guenther - 2022 - International Journal of Cancer - Wiley Online Library
Cancers | Free Full-Text | Comparing Survival after Resection of Pancreatic Cancer with and without Pancreatic Cysts: Nationwide Registry-Based Study
Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study | BMC Medicine | Full Text
![Association between type 2 diabetes and 5-year overall survival in early-stage pancreatic cancer: a retrospective cohort study [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2022/14538/1/fig-2-2x.jpg "Association between type 2 diabetes and 5-year overall survival in early-stage pancreatic cancer: a retrospective cohort study [PeerJ]")
Association between type 2 diabetes and 5-year overall survival in early-stage pancreatic cancer: a retrospective cohort study [PeerJ]
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine | NEJM
Overall survival in patients with pancreatic cancer according to the... | Download Scientific Diagram
Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma - ScienceDirect
